CEFPET

CEFPET SUSPENSION:
Each 5 ml after reconstitution contains: Cefpodoxime 100 mg
CEFPET tablet
Each coated tablet contains: Cefpodoxime 100 mg

Treatment of infections caused by Cefpodoxime-susceptible bacteria in dogs and cats.
Management of skin and soft tissue infections, including wounds and abscesses.
Therapy for urinary tract infections (), including cystitis and pyelonephritis.
Treatment of upper and lower respiratory tract infections.
Effective against both Gram-positive and Gram-negative susceptible bacteria.

Cefpodoxime is a bactericidal agent that targets the bacterial cell wall. Like other - Beta Lactam antibiotics, it works by binding to and inactivating Penicillin-Binding Proteins (PBPs), which are essential enzymes involved in the final cross-linking stage of peptidoglycan synthesis-the primary component of the bacterial cell wall. This inhibition prevents the formation of a stable, structurally sound cell wall, leading to osmotic instability, lysis, and ultimately, bacterial death. Cefpodoxime is generally resistant to many common Beta -lactamase enzymes.

Broad-spectrum efficacy against common skin, respiratory, and UTI pathogens.
Third-generation activity offers improved resistance to Beta-lactamase enzymes.
Twice-daily (BID) dosing is often sufficient, enhancing owner compliance.
Suspension form allows for accurate dosing in small or difficult-to-pill animals.
High oral bioavailability ensures predictable therapeutic drug levels.

Dogs & Cats
General Use: 5 mg per kg body weight, administered every 12 to 24 hours.
Dose and duration (typically 5-14 days) must be determined by the veterinarian.
Tablet: Administer whole or with a small amount of food.
One 100 mg tablet treats a 10-20 Kg animal (at 5 mg/Kg Bwt ).
Suspension: 5 ml (containing 100 mg ) treats a 10-20 Kg animal.
Must be reconstituted as directed and stored according to label instructions.

30 ml bottle with FFI and Strip of 10 tablets

Oral Liquid